©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Apr 28, 2025; 17(4): 106186
Published online Apr 28, 2025. doi: 10.4329/wjr.v17.i4.106186
Published online Apr 28, 2025. doi: 10.4329/wjr.v17.i4.106186
Prognosis value of pituitary neuroendocrine tumor volume
Jian-She Yang, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
Author contributions: Yang JS designed, wrote, and revised the letter.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Corresponding author: Jian-She Yang, PhD, Academic Fellow, Chairman, Dean, Full Professor, Professor, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, No. 301 Yanchang Road, Shanghai 200072, China. 2305499@tongji.edu.cn
Received: February 19, 2025
Revised: March 19, 2025
Accepted: April 11, 2025
Published online: April 28, 2025
Processing time: 63 Days and 3.2 Hours
Revised: March 19, 2025
Accepted: April 11, 2025
Published online: April 28, 2025
Processing time: 63 Days and 3.2 Hours
Core Tip
Core Tip: Pituitary neuroendocrine tumor volume serves as a complementary prognostic factor for disease control in patients with acromegaly. Larger tumors are associated with a higher risk of persistent disease and an increased likelihood of requiring medical treatment following surgery. The consideration of tumor volume is essential in clinical decision-making when managing acromegaly.